Release Date: 05/02/14 09:46 Summary: Fifth Supplementary Bidder's Statement Price Sensitive: Yes Download Document 307.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%